EBQ:CRASH-2 Trial: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{info | {{JC info | ||
| title=Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage | | title=Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage | ||
| abbreviation=CRASH-2 | | abbreviation=CRASH-2 | ||
| Line 13: | Line 13: | ||
| fulltexturl=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext | | fulltexturl=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext | ||
| pdfurl=http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf | | pdfurl=http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf | ||
}} | |||
==Clinical Question== | ==Clinical Question== | ||
Revision as of 02:52, 5 January 2014
incomplete Journal Club Article
Shakur H, et al. "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage". The Lancet. 2010. 376(9734):23-32.
PubMed Full text PDF
PubMed Full text PDF